Facebook Twitter LinkedIn Google Plus RSS

N.J. pharma said to be close to $25B deal

By ,
Actavis could announce a major acquisition this morning.
Actavis could announce a major acquisition this morning. - ()

Multiple media reports say generic drug maker Actavis could announce a major acquisition this morning.

Actavis of Morristown is close to announcing a deal to acquire New York City-based Forest Laboratories, multiple media outlets announced early this morning.

The Wall Street Journal, which was first to announce the news, cited sources saying the deal could be worth around $25 billion.

It would be the latest acquisition for Actavis, one of the world's largest generic drug makers, which relies heavily on mergers and acquisitions to build its company and sustain its growth, according to Bloomberg.

ALSO ON NJBIZ:

U.S. two-man bobsled team, with help from sled created by BMW in Bergen County, wins bronze medal

Groupon’s Presidents Day ‘mistake’ is marketing move of the year

Grapevine: Mum’s the word for Christie

Also Popular on NJBIZ

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!